LZWL02003
LZWL02003 is an anti-neuroinflammatory agent. LZWL02003 has protective effect on MPP+-induced neuronal damage, and reduces the expression of ROS. LZWL02003 improves cognition, memory, learning, and athletic ability in a Rotenone -induced PD rat model. LZWL02003 can be used for research of neurodegenerative disease[1].
Product Specifications
CAS Number
1371564-45-2
UNSPSC
12352005
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lzwl02003.html
Purity
99.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(O)C=C(C)C=C1)NCCC2=CNC3=CC=CC=C32
Molecular Formula
C18H18N2O2
Molecular Weight
294.35
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PAFAH1B2 antibody - N-terminal region (ARP58507_P050)
Recombinant Pseudomonas aeruginosa UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase (arnB)
Recombinant Pseudomonas aeruginosa UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase (arnB)
Recombinant Pseudomonas aeruginosa UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase (arnB)